Market Scenario
Global Particle Therapy Market was valued US$ 860 Mn in 2017 and is expected to reach US$ 1842 Mn by 2026, at a CAGR of 9.99% during a forecast period.
The particle therapy market is majorly segmented into type, product & service, system, cancer type, application, and region.
Further, particle therapy market based on type includes proton therapy, and heavy ion therapy. Particle therapy market in terms of product & service is classified into cyclotrons, synchrotrons, synchrocyclotrons, and others. Based on the particle therapy market, system segment is divided into multi-room systems, and single-room systems. In terms of cancer type segment particle therapy market is categorized into pediatric & prostate cancer, breast cancer, lung cancer, head & neck cancer, and other cancers. Further, particle therapy market based on application includes treatment applications, and research applications.
Based on regions, the global particle therapy market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa.
Global Particle Therapy Market
In terms of product & services, synchrotron segment is expected to grow at the highest rate during the forecast period due to the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.
Based on the type, proton therapy is expected to be the largest contributor to the particle therapy market due to the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays.
On the basic of application, treatment applications are expected to be the largest contributor to the particle therapy market due to the growing number of cancer patients globally, increasing government initiatives such as aimed at equipping or upgrading hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies.
The major driving factor of particle therapy market is the growing global prevalence of cancer, growing adoption of particle therapy in clinical trials, advantages offered by particle therapy over photon therapy, and the increasing number of particle therapy centers worldwide. Furthermore, favorable government initiatives that are creating awareness and promoting the adoption of proton therapy among key end users are some of the other major factors driving the growth of the particle therapy market.
Particle therapy is costly may hamper the market growth.
By region, The Asia Pacific region is expected to offer significant growth opportunities for players operating in the particle therapy market owing to the increasing healthcare expenditure and growth initiatives to promote the use of advanced particle therapy technologies in Asia Pacific countries.
Key players operating in the global particle therapy market are Advanced Oncotherapy PLC., Danfysik A/S, Hitachi, Ltd., Ion Beam Applications SA, Mevion Medical Systems, Inc., and Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., and Varian Medical Systems, Inc.
Scope of Global Particle Therapy Market:
Global Particle Therapy Market, by Type:
• Proton Therapy
• Heavy Ion Therapy
Global Particle Therapy Market, by Product & Service:
• Cyclotrons
• Synchrotrons
• Synchrocyclotrons
• Others
Global Particle Therapy Market, by System:
• Multi-room Systems
• Single-room Systems
Global Particle Therapy Market by Cancer Type:
• Pediatric & Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head & Neck Cancer
• Other Cancers
Global Particle Therapy Market by Application:
• Treatment Applications
• Research Applications
Global Particle Therapy Market, by Region:
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
Key players operating in Global Particle Therapy Market:
• Advanced Oncotherapy PLC.
• Danfysik A/S
• Hitachi, Ltd.
• Ion Beam Applications Sa
• Mevion Medical Systems, Inc.
• Optivus Proton Therapy, Inc.
• Protom International, Inc.
• Provision Healthcare, LLC
• Sumitomo Heavy Industries, Ltd.
• Varian Medical Systems, Inc.
Table of Contents
Global Particle Therapy Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Particle Therapy Market Size, by Market Value (US$ MN) and Market, by Region
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.4. Global Particle Therapy Market Industry Trends and Emerging Technologies
5. Global Particle Therapy Market Analysis and Forecast
5.1. Global Particle Therapy Market Analysis and Forecast
5.2. Global Particle Therapy Market Size & Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America
6. Global Particle Therapy Market Analysis and Forecast, by Type
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Particle Therapy Market Value Share Analysis, by Type
6.4. Global Particle Therapy Market Size (US$ Mn) Forecast, by Type
6.5. Global Particle Therapy Market Analysis, by Type
6.6. Global Particle Therapy Market Attractiveness Analysis, by Type
7. Global Particle Therapy Market Analysis and Forecast, by Product & Services
7.1. Introduction and Definition
7.2. Global Particle Therapy Market Value Share Analysis, by Product & Services
7.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Product & Services
7.4. Global Particle Therapy Market Analysis, by Product & Services
7.5. Global Particle Therapy Market Attractiveness Analysis, by Product & Services
8. Global Particle Therapy Market Analysis and Forecast, by System
8.1. Introduction and Definition
8.2. Global Particle Therapy Market Value Share Analysis, by System
8.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by System
8.4. Global Particle Therapy Market Analysis, by System
8.5. Global Particle Therapy Market Attractiveness Analysis, by System
9. Global Particle Therapy Market Analysis and Forecast, by Cancer Type
9.1. Introduction and Definition
9.2. Global Particle Therapy Market Value Share Analysis, by Cancer Type
9.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Cancer Type
9.4. Global Particle Therapy Market Analysis, by Cancer Type
9.5. Global Particle Therapy Market Attractiveness Analysis, by Cancer Type
10. Global Particle Therapy Market Analysis and Forecast, by Application
10.1. Introduction and Definition
10.2. Global Particle Therapy Market Value Share Analysis, by Application
10.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Application
10.4. Global Particle Therapy Market Analysis, by Application
10.5. Global Particle Therapy Market Attractiveness Analysis, by Application
11. Global Particle Therapy Market Analysis, by Region
11.1. Global Particle Therapy Market Value Share Analysis, by Region
11.2. Global Particle Therapy Market Size (US$ Mn) Forecast, by Region
11.3. Global Particle Therapy Market Attractiveness Analysis, by Region
12. North America Particle Therapy Market Analysis
12.1. Key Findings
12.2. North America Particle Therapy Market Overview
12.3. North America Particle Therapy Market Value Share Analysis, by Type
12.4. North America Particle Therapy Market Forecast, by Type
12.4.1. Proton Therapy
12.4.2. Heavy Ion Therapy
12.5. North America Particle Therapy Market Value Share Analysis, by Product & Services
12.6. North America Particle Therapy Market Forecast, by Product & Services
12.6.1. Cyclotrons
12.6.2. Synchrotrons
12.6.3. Synchrocyclotrons
12.6.4. Others
12.7. North America Particle Therapy Market Value Share Analysis, by System
12.8. North America Particle Therapy Market Forecast, by System
12.8.1. Multi-room Systems
12.8.2. Single-room Systems
12.9. North America Particle Therapy Market Value Share Analysis, by Cancer Type
12.10. North America Particle Therapy Market Forecast, by Cancer Type
12.10.1. Pediatric & Prostate Cancer
12.10.2. Breast Cancer
12.10.3. Lung Cancer
12.10.4. Head & Neck Cancer
12.10.5. Others
12.11. North America Particle Therapy Market Value Share Analysis, by Application
12.12. North America Particle Therapy Market Forecast, by Application
12.12.1. Treatment Applications
12.12.2. Research Applications
12.13. North America Particle Therapy Market Value Share Analysis, by Country
12.14. North America Particle Therapy Market Forecast, by Country
12.14.1. U.S.
12.14.2. Canada
12.15. North America Particle Therapy Market Analysis, by Country
12.16. U.S. Particle Therapy Market Forecast, by Type
12.16.1. Proton Therapy
12.16.2. Heavy Ion Therapy
12.17. U.S. Particle Therapy Market Forecast, by Product & Services
12.17.1. Cyclotrons
12.17.2. Synchrotrons
12.17.3. Synchrocyclotrons
12.17.4. Others
12.18. U.S. Particle Therapy Market Forecast, by System
12.18.1. Multi-room Systems
12.18.2. Single-room Systems
12.19. U.S. Particle Therapy Market Forecast, by Cancer Type
12.19.1. Pediatric & Prostate Cancer
12.19.2. Breast Cancer
12.19.3. Lung Cancer
12.19.4. Head & Neck Cancer
12.19.5. Others
12.20. U.S. Particle Therapy Market Forecast, by Application
12.20.1. Treatment Applications
12.20.2. Research Applications
12.21. Canada Particle Therapy Market Forecast, by Type
12.21.1. Proton Therapy
12.21.2. Heavy Ion Therapy
12.22. Canada Particle Therapy Market Forecast, by Product & Services
12.22.1. Cyclotrons
12.22.2. Synchrotrons
12.22.3. Synchrocyclotrons
12.22.4. Others
12.23. Canada Particle Therapy Market Forecast, by System
12.23.1. Multi-room Systems
12.23.2. Single-room Systems
12.24. Canada Particle Therapy Market Forecast, by Cancer Type
12.24.1. Pediatric & Prostate Cancer
12.24.2. Breast Cancer
12.24.3. Lung Cancer
12.24.4. Head & Neck Cancer
12.24.5. Others
12.25. Canada Particle Therapy Market Forecast, by Application
12.25.1. Treatment Applications
12.25.2. Research Applications
12.26. North America Particle Therapy Market Attractiveness Analysis
12.26.1. By Type
12.26.2. By Product & Services
12.26.3. By System
12.26.4. By Cancer Type
12.26.5. By Application
12.27. PEST Analysis
13. Europe Particle Therapy Market Analysis
13.1. Key Findings
13.2. Europe Particle Therapy Market Overview
13.3. Europe Particle Therapy Market Value Share Analysis, by Type
13.4. Europe Particle Therapy Market Forecast, by Type
13.4.1. Proton Therapy
13.4.2. Heavy Ion Therapy
13.5. Europe Particle Therapy Market Value Share Analysis, by Product & Services
13.6. Europe Particle Therapy Market Forecast, by Product & Services
13.6.1. Cyclotrons
13.6.2. Synchrotrons
13.6.3. Synchrocyclotrons
13.6.4. Others
13.7. Europe Particle Therapy Market Value Share Analysis, by System
13.8. Europe Particle Therapy Market Forecast, by System
13.8.1. Multi-room Systems
13.8.2. Single-room Systems
13.9. Europe Particle Therapy Market Value Share Analysis, by Cancer Type
13.10. Europe Particle Therapy Market Forecast, by Cancer Type
13.10.1. Pediatric & Prostate Cancer
13.10.2. Breast Cancer
13.10.3. Lung Cancer
13.10.4. Head & Neck Cancer
13.10.5. Others
13.11. Europe Particle Therapy Market Value Share Analysis, by Application
13.12. Europe Particle Therapy Market Forecast, by Application
13.12.1. Treatment Applications
13.12.2. Research Applications
13.13. Europe Particle Therapy Market Value Share Analysis, by Country
13.14. Europe Particle Therapy Market Forecast, by Country
13.14.1. Germany
13.14.2. U.K.
13.14.3. France
13.14.4. Italy
13.14.5. Spain
13.14.6. Rest of Europe
13.15. Europe Particle Therapy Market Analysis, by Country/ Sub-region
13.16. Germany Particle Therapy Market Forecast, by Type
13.16.1. Proton Therapy
13.16.2. Heavy Ion Therapy
13.17. Germany Particle Therapy Market Forecast, by Product & Services
13.17.1. Cyclotrons
13.17.2. Synchrotrons
13.17.3. Synchrocyclotrons
13.17.4. Others
13.18. Germany Particle Therapy Market Forecast, by System
13.18.1. Multi-room Systems
13.18.2. Single-room Systems
13.19. Germany Particle Therapy Market Forecast, by Cancer Type
13.19.1. Pediatric & Prostate Cancer
13.19.2. Breast Cancer
13.19.3. Lung Cancer
13.19.4. Head & Neck Cancer
13.19.5. Others
13.20. Germany Particle Therapy Market Forecast, by Application
13.20.1. Treatment Applications
13.20.2. Research Applications
13.21. U.K. Particle Therapy Market Forecast, by Type
13.21.1. Proton Therapy
13.21.2. Heavy Ion Therapy
13.22. U.K. Particle Therapy Market Forecast, by Product & Services
13.22.1. Cyclotrons
13.22.2. Synchrotrons
13.22.3. Synchrocyclotrons
13.22.4. Others
13.23. U.K. Particle Therapy Market Forecast, by System
13.23.1. Multi-room Systems
13.23.2. Single-room Systems
13.24. U.K. Particle Therapy Market Forecast, by Cancer Type
13.24.1. Pediatric & Prostate Cancer
13.24.2. Breast Cancer
13.24.3. Lung Cancer
13.24.4. Head & Neck Cancer
13.24.5. Others
13.25. U.K. Particle Therapy Market Forecast, by Application
13.25.1. Treatment Applications
13.25.2. Research Applications
13.26. France Particle Therapy Market Forecast, by Type
13.26.1. Proton Therapy
13.26.2. Heavy Ion Therapy
13.27. France Particle Therapy Market Forecast, by Product & Services
13.27.1. Cyclotrons
13.27.2. Synchrotrons
13.27.3. Synchrocyclotrons
13.27.4. Others
13.28. France Particle Therapy Market Forecast, by System
13.28.1. Multi-room Systems
13.28.2. Single-room Systems
13.29. France Particle Therapy Market Forecast, by Cancer Type
13.29.1. Pediatric & Prostate Cancer
13.29.2. Breast Cancer
13.29.3. Lung Cancer
13.29.4. Head & Neck Cancer
13.29.5. Others
13.30. France Particle Therapy Market Forecast, by Application
13.30.1. Treatment Applications
13.30.2. Research Applications
13.31. Italy Particle Therapy Market Forecast, by Type
13.31.1. Proton Therapy
13.31.2. Heavy Ion Therapy
13.32. Italy Particle Therapy Market Forecast, by Product & Services
13.32.1. Cyclotrons
13.32.2. Synchrotrons
13.32.3. Synchrocyclotrons
13.32.4. Others
13.33. Italy Particle Therapy Market Forecast, by System
13.33.1. Multi-room Systems
13.33.2. Single-room Systems
13.34. Italy Particle Therapy Market Forecast, by Cancer Type
13.34.1. Pediatric & Prostate Cancer
13.34.2. Breast Cancer
13.34.3. Lung Cancer
13.34.4. Head & Neck Cancer
13.34.5. Others
13.35. Italy Particle Therapy Market Forecast, by Application
13.35.1. Treatment Applications
13.35.2. Research Applications
13.36. Spain Particle Therapy Market Forecast, by Type
13.36.1. Proton Therapy
13.36.2. Heavy Ion Therapy
13.37. Spain Particle Therapy Market Forecast, by Product & Services
13.37.1. Cyclotrons
13.37.2. Synchrotrons
13.37.3. Synchrocyclotrons
13.37.4. Others
13.38. Spain Particle Therapy Market Forecast, by System
13.38.1. Multi-room Systems
13.38.2. Single-room Systems
13.39. Spain Particle Therapy Market Forecast, by Cancer Type
13.39.1. Pediatric & Prostate Cancer
13.39.2. Breast Cancer
13.39.3. Lung Cancer
13.39.4. Head & Neck Cancer
13.39.5. Others
13.40. Spain Particle Therapy Market Forecast, by Application
13.40.1. Treatment Applications
13.40.2. Research Applications
13.41. Rest of Europe Particle Therapy Market Forecast, by Type
13.41.1. Proton Therapy
13.41.2. Heavy Ion Therapy
13.42. Rest of Europe Particle Therapy Market Forecast, by Product & Services
13.42.1. Cyclotrons
13.42.2. Synchrotrons
13.42.3. Synchrocyclotrons
13.42.4. Others
13.43. Rest of Europe Particle Therapy Market Forecast, by System
13.43.1. Multi-room Systems
13.43.2. Single-room Systems
13.44. Rest of Europe Particle Therapy Market Forecast, by Cancer Type
13.44.1. Pediatric & Prostate Cancer
13.44.2. Breast Cancer
13.44.3. Lung Cancer
13.44.4. Head & Neck Cancer
13.44.5. Others
13.45. Rest of Europe Particle Therapy Market Forecast, by Application
13.45.1. Treatment Applications
13.45.2. Research Applications
13.46. Europe Particle Therapy Market Attractiveness Analysis
13.46.1. By Type
13.46.2. By Product & Services
13.46.3. By System
13.46.4. By Cancer Type
13.46.5. By Application
13.47. PEST Analysis
14. Asia Pacific Particle Therapy Market Analysis
14.1. Key Findings
14.2. Asia Pacific Particle Therapy Market Overview
14.3. Asia Pacific Particle Therapy Market Value Share Analysis, by Type
14.4. Asia Pacific Particle Therapy Market Forecast, by Type
14.4.1. Proton Therapy
14.4.2. Heavy Ion Therapy
14.5. Asia Pacific Particle Therapy Market Value Share Analysis, by Product & Services
14.6. Asia Pacific Particle Therapy Market Forecast, by Product & Services
14.6.1. Cyclotrons
14.6.2. Synchrotrons
14.6.3. Synchrocyclotrons
14.6.4. Others
14.7. Asia Pacific Particle Therapy Market Value Share Analysis, by System
14.8. Asia Pacific Particle Therapy Market Forecast, by System
14.8.1. Multi-room Systems
14.8.2. Single-room Systems
14.9. Asia Pacific Particle Therapy Market Value Share Analysis, by Cancer Type
14.10. Asia Pacific Particle Therapy Market Forecast, by Cancer Type
14.10.1. Pediatric & Prostate Cancer
14.10.2. Breast Cancer
14.10.3. Lung Cancer
14.10.4. Head & Neck Cancer
14.10.5. Others
14.11. Asia Pacific Particle Therapy Market Value Share Analysis, by Application
14.12. Asia Pacific Particle Therapy Market Forecast, by Application
14.12.1. Treatment Applications
14.12.2. Research Applications
14.13. Asia Pacific Particle Therapy Market Value Share Analysis, by Country
14.14. Asia Pacific Particle Therapy Market Forecast, by Country
14.14.1. China
14.14.2. India
14.14.3. Japan
14.14.4. ASEAN
14.14.5. Rest of Asia Pacific
14.15. Asia Pacific Particle Therapy Market Analysis, by Country/ Sub-region
14.16. China Particle Therapy Market Forecast, by Type
14.16.1. Proton Therapy
14.16.2. Heavy Ion Therapy
14.17. China Particle Therapy Market Forecast, by Product & Services
14.17.1. Cyclotrons
14.17.2. Synchrotrons
14.17.3. Synchrocyclotrons
14.17.4. Others
14.18. China Particle Therapy Market Forecast, by System
14.18.1. Multi-room Systems
14.18.2. Single-room Systems
14.19. China Particle Therapy Market Forecast, by Cancer Type
14.19.1. Pediatric & Prostate Cancer
14.19.2. Breast Cancer
14.19.3. Lung Cancer
14.19.4. Head & Neck Cancer
14.19.5. Others
14.20. China Particle Therapy Market Forecast, by Application
14.20.1. Treatment Applications
14.20.2. Research Applications
14.21. India Particle Therapy Market Forecast, by Type
14.21.1. Proton Therapy
14.21.2. Heavy Ion Therapy
14.22. India Particle Therapy Market Forecast, by Product & Services
14.22.1. Cyclotrons
14.22.2. Synchrotrons
14.22.3. Synchrocyclotrons
14.22.4. Others
14.23. India Particle Therapy Market Forecast, by System
14.23.1. Multi-room Systems
14.23.2. Single-room Systems
14.24. India Particle Therapy Market Forecast, by Cancer Type
14.24.1. Pediatric & Prostate Cancer
14.24.2. Breast Cancer
14.24.3. Lung Cancer
14.24.4. Head & Neck Cancer
14.24.5. Others
14.25. India Particle Therapy Market Forecast, by Application
14.25.1. Treatment Applications
14.25.2. Research Applications
14.26. Japan Particle Therapy Market Forecast, by Type
14.26.1. Proton Therapy
14.26.2. Heavy Ion Therapy
14.27. Japan Particle Therapy Market Forecast, by Product & Services
14.27.1. Cyclotrons
14.27.2. Synchrotrons
14.27.3. Synchrocyclotrons
14.27.4. Others
14.28. Japan Particle Therapy Market Forecast, by System
14.28.1. Multi-room Systems
14.28.2. Single-room Systems
14.29. Japan Particle Therapy Market Forecast, by Cancer Type
14.29.1. Pediatric & Prostate Cancer
14.29.2. Breast Cancer
14.29.3. Lung Cancer
14.29.4. Head & Neck Cancer
14.29.5. Others
14.30. Japan Particle Therapy Market Forecast, by Application
14.30.1. Treatment Applications
14.30.2. Research Applications
14.31. ASEAN Particle Therapy Market Forecast, by Type
14.31.1. Proton Therapy
14.31.2. Heavy Ion Therapy
14.32. ASEAN Particle Therapy Market Forecast, by Product & Services
14.32.1. Cyclotrons
14.32.2. Synchrotrons
14.32.3. Synchrocyclotrons
14.32.4. Others
14.33. ASEAN Particle Therapy Market Forecast, by System
14.33.1. Multi-room Systems
14.33.2. Single-room Systems
14.34. ASEAN Particle Therapy Market Forecast, by Cancer Type
14.34.1. Pediatric & Prostate Cancer
14.34.2. Breast Cancer
14.34.3. Lung Cancer
14.34.4. Head & Neck Cancer
14.34.5. Others
14.35. ASEAN Particle Therapy Market Forecast, by Application
14.35.1. Treatment Applications
14.35.2. Research Applications
14.36. Rest of Asia Pacific Particle Therapy Market Forecast, by Type
14.36.1. Proton Therapy
14.36.2. Heavy Ion Therapy
14.37. Rest of Asia Pacific Particle Therapy Market Forecast, by Product & Services
14.37.1. Cyclotrons
14.37.2. Synchrotrons
14.37.3. Synchrocyclotrons
14.37.4. Others
14.38. Rest of Asia Pacific Particle Therapy Market Forecast, by System
14.38.1. Multi-room Systems
14.38.2. Single-room Systems
14.39. Rest of Asia Pacific Particle Therapy Market Forecast, by Cancer Type
14.39.1. Pediatric & Prostate Cancer
14.39.2. Breast Cancer
14.39.3. Lung Cancer
14.39.4. Head & Neck Cancer
14.39.5. Others
14.40. Rest of Asia Pacific Particle Therapy Market Forecast, by Application
14.40.1. Treatment Applications
14.40.2. Research Applications
14.41. Asia Pacific Particle Therapy Market Attractiveness Analysis
14.41.1. By Type
14.41.2. By Product & Services
14.41.3. By System
14.41.4. By Cancer Type
14.41.5. By Application
14.42. PEST Analysis
15. Middle East & Africa Particle Therapy Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Particle Therapy Market Overview
15.3. Middle East & Africa Particle Therapy Market Value Share Analysis, by Type
15.4. Middle East & Africa Particle Therapy Market Forecast, by Type
15.4.1. Proton Therapy
15.4.2. Heavy Ion Therapy
15.5. Middle East & Africa Particle Therapy Market Value Share Analysis, by Product & Services
15.6. Middle East & Africa Particle Therapy Market Forecast, by Product & Services
15.6.1. Cyclotrons
15.6.2. Synchrotrons
15.6.3. Synchrocyclotrons
15.6.4. Others
15.7. Middle East & Africa Particle Therapy Market Value Share Analysis, by System
15.8. Middle East & Africa Particle Therapy Market Forecast, by System
15.8.1. Multi-room Systems
15.8.2. Single-room Systems
15.9. Middle East & Africa Particle Therapy Market Value Share Analysis, by Cancer Type
15.10. Middle East & Africa Particle Therapy Market Forecast, by Cancer Type
15.10.1. Pediatric & Prostate Cancer
15.10.2. Breast Cancer
15.10.3. Lung Cancer
15.10.4. Head & Neck Cancer
15.10.5. Others
15.11. Middle East & Africa Particle Therapy Market Value Share Analysis, by Application
15.12. Middle East & Africa Particle Therapy Market Forecast, by Application
15.12.1. Treatment Applications
15.12.2. Research Applications
15.13. Middle East & Africa Particle Therapy Market Value Share Analysis, by Country
15.14. Middle East & Africa Particle Therapy Market Forecast, by Country
15.14.1. GCC
15.14.2. South Africa
15.14.3. Rest of Middle East & Africa
15.15. Middle East & Africa Particle Therapy Market Analysis, by Country/ Sub-region
15.16. GCC Particle Therapy Market Forecast, by Type
15.16.1. Proton Therapy
15.16.2. Heavy Ion Therapy
15.17. GCC Particle Therapy Market Forecast, by Product & Services
15.17.1. Cyclotrons
15.17.2. Synchrotrons
15.17.3. Synchrocyclotrons
15.17.4. Others
15.18. GCC Particle Therapy Market Forecast, by System
15.18.1. Multi-room Systems
15.18.2. Single-room Systems
15.19. GCC Particle Therapy Market Forecast, by Cancer Type
15.19.1. Pediatric & Prostate Cancer
15.19.2. Breast Cancer
15.19.3. Lung Cancer
15.19.4. Head & Neck Cancer
15.19.5. Others
15.20. GCC Particle Therapy Market Forecast, by Application
15.20.1. Treatment Applications
15.20.2. Research Applications
15.21. South Africa Particle Therapy Market Forecast, by Type
15.21.1. Proton Therapy
15.21.2. Heavy Ion Therapy
15.22. South Africa Particle Therapy Market Forecast, by Product & Services
15.22.1. Cyclotrons
15.22.2. Synchrotrons
15.22.3. Synchrocyclotrons
15.22.4. Others
15.23. South Africa Particle Therapy Market Forecast, by System
15.23.1. Multi-room Systems
15.23.2. Single-room Systems
15.24. South Africa Particle Therapy Market Forecast, by Cancer Type
15.24.1. Pediatric & Prostate Cancer
15.24.2. Breast Cancer
15.24.3. Lung Cancer
15.24.4. Head & Neck Cancer
15.24.5. Others
15.25. South Africa Particle Therapy Market Forecast, by Application
15.25.1. Treatment Applications
15.25.2. Research Applications
15.26. Rest of Middle East & Africa Particle Therapy Market Forecast, by Type
15.26.1. Proton Therapy
15.26.2. Heavy Ion Therapy
15.27. Rest of Middle East & Africa Particle Therapy Market Forecast, by Product & Services
15.27.1. Cyclotrons
15.27.2. Synchrotrons
15.27.3. Synchrocyclotrons
15.27.4. Others
15.28. Rest of Middle East & Africa Particle Therapy Market Forecast, by System
15.28.1. Multi-room Systems
15.28.2. Single-room Systems
15.29. Rest of Middle East & Africa Particle Therapy Market Forecast, by Cancer Type
15.29.1. Pediatric & Prostate Cancer
15.29.2. Breast Cancer
15.29.3. Lung Cancer
15.29.4. Head & Neck Cancer
15.29.5. Others
15.30. Rest of Middle East & Africa Particle Therapy Market Forecast, by Application
15.30.1. Treatment Applications
15.30.2. Research Applications
15.31. Middle East & Africa Particle Therapy Market Attractiveness Analysis
15.31.1. By Type
15.31.2. By Product & Services
15.31.3. By System
15.31.4. By Cancer Type
15.31.5. By Application
15.32. PEST Analysis
16. Latin America Particle Therapy Market Analysis
16.1. Key Findings
16.2. Latin America Particle Therapy Market Overview
16.3. Latin America Particle Therapy Market Value Share Analysis, by Type
16.4. Latin America Particle Therapy Market Forecast, by Type
16.4.1. Proton Therapy
16.4.2. Heavy Ion Therapy
16.5. Latin America Particle Therapy Market Value Share Analysis, by Product & Services
16.6. Latin America Particle Therapy Market Forecast, by Product & Services
16.6.1. Cyclotrons
16.6.2. Synchrotrons
16.6.3. Synchrocyclotrons
16.6.4. Others
16.7. Latin America Particle Therapy Market Value Share Analysis, by System
16.8. Latin America Particle Therapy Market Forecast, by System
16.8.1. Multi-room Systems
16.8.2. Single-room Systems
16.9. Latin America Particle Therapy Market Value Share Analysis, by Cancer Type
16.10. Latin America Particle Therapy Market Forecast, by Cancer Type
16.10.1. Pediatric & Prostate Cancer
16.10.2. Breast Cancer
16.10.3. Lung Cancer
16.10.4. Head & Neck Cancer
16.10.5. Others
16.11. Latin America Particle Therapy Market Value Share Analysis, by Application
16.12. Latin America Particle Therapy Market Forecast, by Application
16.12.1. Treatment Applications
16.12.2. Research Applications
16.13. Latin America Particle Therapy Market Value Share Analysis, by Country
16.14. Latin America Particle Therapy Market Forecast, by Country
16.14.1. Brazil
16.14.2. Mexico
16.14.3. Rest of Latin America
16.15. Latin America Particle Therapy Market Analysis, by Country/ Sub-region
16.16. Brazil Particle Therapy Market Forecast, by Type
16.16.1. Proton Therapy
16.16.2. Heavy Ion Therapy
16.17. Brazil Particle Therapy Market Forecast, by Product & Services
16.17.1. Cyclotrons
16.17.2. Synchrotrons
16.17.3. Synchrocyclotrons
16.17.4. Others
16.18. Brazil Particle Therapy Market Forecast, by System
16.18.1. Multi-room Systems
16.18.2. Single-room Systems
16.19. Brazil Particle Therapy Market Forecast, by Cancer Type
16.19.1. Pediatric & Prostate Cancer
16.19.2. Breast Cancer
16.19.3. Lung Cancer
16.19.4. Head & Neck Cancer
16.19.5. Others
16.20. Brazil Particle Therapy Market Forecast, by Application
16.20.1. Treatment Applications
16.20.2. Research Applications
16.21. Mexico Particle Therapy Market Forecast, by Type
16.21.1. Proton Therapy
16.21.2. Heavy Ion Therapy
16.22. Mexico Particle Therapy Market Forecast, by Product & Services
16.22.1. Cyclotrons
16.22.2. Synchrotrons
16.22.3. Synchrocyclotrons
16.22.4. Others
16.23. Mexico Particle Therapy Market Forecast, by System
16.23.1. Multi-room Systems
16.23.2. Single-room Systems
16.24. Mexico Particle Therapy Market Forecast, by Cancer Type
16.24.1. Pediatric & Prostate Cancer
16.24.2. Breast Cancer
16.24.3. Lung Cancer
16.24.4. Head & Neck Cancer
16.24.5. Others
16.25. Mexico Particle Therapy Market Forecast, by Application
16.25.1. Treatment Applications
16.25.2. Research Applications
16.26. Rest of Latin America Particle Therapy Market Forecast, by Type
16.26.1. Proton Therapy
16.26.2. Heavy Ion Therapy
16.27. Rest of Latin America Particle Therapy Market Forecast, by Product & Services
16.27.1. Cyclotrons
16.27.2. Synchrotrons
16.27.3. Synchrocyclotrons
16.27.4. Others
16.28. Rest of Latin America Particle Therapy Market Forecast, by System
16.28.1. Multi-room Systems
16.28.2. Single-room Systems
16.29. Rest of Latin America Particle Therapy Market Forecast, by Cancer Type
16.29.1. Pediatric & Prostate Cancer
16.29.2. Breast Cancer
16.29.3. Lung Cancer
16.29.4. Head & Neck Cancer
16.29.5. Others
16.30. Rest of Latin America Particle Therapy Market Forecast, by Application
16.30.1. Treatment Applications
16.30.2. Research Applications
16.31. Latin America Particle Therapy Market Attractiveness Analysis
16.31.1. By Type
16.31.2. By Product & Services
16.31.3. By System
16.31.4. By Cancer Type
16.31.5. By Application
16.32. PEST Analysis
17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.3. Company Profiles: Key Players
17.3.1. Danfysik A/S
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Business Strategy
17.3.1.4. Recent Developments
17.3.1.5. Manufacturing Footprint
17.3.2. Advanced Oncotherapy PLC.
17.3.3. Hitachi, Ltd.
17.3.4. Ion Beam Applications Sa
17.3.5. Mevion Medical Systems, Inc.
17.3.6. Optivus Proton Therapy, Inc.
17.3.7. Protom International, Inc.
17.3.8. Provision Healthcare, LLC
17.3.9. Sumitomo Heavy Industries, Ltd.
17.3.10. Varian Medical Systems, Inc.
18. Primary Key Insights
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2020. All Rights Reserved.